Glycolipid Antigens: Potential in Cancer Detection and Diagnosis

  • Gary R. Matyas
  • Vivian P. Walter-Doelling
  • Christine Ferroli
  • Kenneth R. Pennington
  • Diane Pikaard
  • D. James Morré
Part of the Methodological Surveys in Biochemistry and Analysis book series (MSBA, volume 15B)


A number of tumour-specific monoclonal antibodies (MAb’s) have been produced which are directed to unique carbohydrate structures associated with cellular membranes as glycolipids rather than glycoproteins (as reviewed by S.-I. Hakomori [1]). The potential of other more common glycolipid antigens for use in cancer detection and diagnosis is now addressed with especial emphasis on a specific role in early detection. The assays now reported concern glycolipids in sera from hepatocarcinogen-fed rats and cancer patients.


Sialic Acid Serum Sialic Acid Total Ganglioside Glycolipid Antigen Neutral Glycosphingolipids 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hakomori, S.-I. (1984) Ann. Rev. Immunol. 2, 103–126.CrossRefGoogle Scholar
  2. 2.
    Koprowski, H., Steplewski, Z., Mitchell, K., Herly, M., Herly, D., Fuhrer, P. (1979) Soma. Cell Genet. 5, 957–962.CrossRefGoogle Scholar
  3. 3.
    Kannagi, R., Nudelman, E, Levery, S.B., Hakomori, S. (1982) J. Biol. Chem. 257, 14865–14874.Google Scholar
  4. 4.
    Hakomori, S., Nudelman, E., Kannagi, R., Levery, S.B. (1982) Biochem. Biophys. Res. Comm. 109, 36–44.CrossRefGoogle Scholar
  5. 5.
    Pukel, C.A., Lloyd, K.O., Trabassos, L.R., Dippold, W.G., Oettgen, H.F., Old, L.J. (1982) J. Exp. Med. 155, 1133–1147.CrossRefGoogle Scholar
  6. 6.
    Nudelman, E., Hakomori, S.-I., Kannagi, R., Levery, S., Yeh, M.Y., Hellstrom, K.E. , Hellstrom, I. (1982) J. Biol. Chem. 257, 12752–12756.Google Scholar
  7. 7.
    Nudelman, E., Kannagi, R., Hakomori, S.-I., Parsons, M., Lipinski, M., Wiels, J., Fellons, M., Tursz, T. (1983) Science 220, 509–511.CrossRefGoogle Scholar
  8. 8.
    Kloppel, T.M. , Morré, D.J. (1980) J.Nat. Cancer Inst. 64, 1401–1411.Google Scholar
  9. 9.
    Creek, K.E., Walter, V.P., Evers, D., Yeo,E., Elliott, W.L., Heinstein, P.F., Morré, D.M. , Morré, D.J. (1984) Biochim. Biophys. Acta 793,133–140.Google Scholar
  10. 10.
    Elliott, W.L., Sawick, D.P., DeFrees, S.A., Heinstein, P.F., Cassady, J.M., Morré, D.J. (1984) Biochim. Biophys. Acta 800, 194–201.CrossRefGoogle Scholar
  11. 11.
    Kloppel, T.M., Keenan, T.W., Freeman, M.J., Morré, D.J. (1977) Proc. Nat. Acad. Sci. 74, 3011–3013.CrossRefGoogle Scholar
  12. 12.
    Warren, L. (1959) J. BioZ. Chem. 234,1971–1975.Google Scholar
  13. 13.
    Jourdian, G.W., Dean, L. , Roseman, S. (1971) J. Biol. Chem. 246,430–435.Google Scholar
  14. 14.
    Ledeen, R.W., Yu, R.K., Eng, L.F. (1973) J. Neurochem. 21, 829–839.CrossRefGoogle Scholar
  15. 15.
    Lowry, O.H., Rosenbrough, N.J., Farr, A.L., Randall, R.J. (1951) J. Biol. Chem. 193, 265–275.Google Scholar
  16. 16.
    Walter, V.P., Kloppel, T.M., Deimling, I.G., Morré, D.J. (1980) Cancer Biochem. Biophys. 4, 145–151.Google Scholar
  17. 17.
    Koscielak, J., Józwiak, W., Pacuszka, T., Miller-Podraza, H. (1979) inGlycoconjugates (Schauer, R., Boer, P., Buddecke, E., et al., eds.), Georg Thieme Verlag, Stuttgart, pp. 619–620.Google Scholar
  18. 18.
    Sallay, S.I., Prosise, W.N., Morré, D.J. , Matyas, G.R. (1985) Cancer Res. 45,in press.Google Scholar
  19. 19.
    Ginsburg, V. (1978) Meths. Enzymol. 50, 64–84.CrossRefGoogle Scholar
  20. 20.
    Hakomori, S.-I. (1973) Adv. Cancer Res. 18, 265–315.CrossRefGoogle Scholar
  21. 21.
    Brady, R.O., Fishman, P. (1974) Biochim. Biophys. Acta 335, 121–148.Google Scholar
  22. 22.
    Richardson, C.L., Baker. S.R. Morré, D.J., Morré, D.M., Keenan, T.W. (1975) Biochim. Biophys. Acta 417,175–186.Google Scholar
  23. 23.
    Merritt, W.D., Richardson, C.L., Keenan, T.W. , Morré, D.J. (1978) J. Nat. Cancer Inst. 60,1313–1328;also 1329–1337.Google Scholar
  24. 24.
    Kloppel, T.M., Franz, C.L., Morré, D.J., Richardson, R.C. (1978) Am. J. Vet. Res. 39, 1377–1380.Google Scholar
  25. 25.
    Bremer, E.G., Hakomori, S.-I., Bowen-Pope, D.F., Raines, E., Ross, R. (1984) J. Biol. Chem. 259, 6818–6825.Google Scholar
  26. 26.
    Hakomori, S.-I. (1984) in Monoclonal Antibodies and Functional CeZZ Lines (Kenneth, R.H., et al., eds.), Plenum, New York, pp. 67–100.CrossRefGoogle Scholar
  27. 27.
    Higashi, H., Ikuta, K., Ueda, S., Kato, S., Hirabayashi, Y., Matsumoto, M. , Naiki, M. (1984) J. Biochem. 95,785–794 (see also 94,327–330).Google Scholar
  28. 28.
    Kannagi, R., Levery, S.B., Ishigami, F., Hakomori, S.I., Shevinsky, L.H., Knowles, B.B. , Solter, D. (1983) J. Biol. Chem. 258, 8934–8942.Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Gary R. Matyas
    • 1
  • Vivian P. Walter-Doelling
    • 1
  • Christine Ferroli
    • 1
  • Kenneth R. Pennington
    • 1
    • 2
  • Diane Pikaard
    • 1
  • D. James Morré
    • 1
  1. 1.Purdue Cancer CenterPurdue UniversityWest LafayetteUSA
  2. 2.Arnett ClinicLafayetteUSA

Personalised recommendations